Tags: cancer immunotherapy trials network, chemotherapy, CITN, Clinical Research, CRISPR, fertility after cancer, gene editing, Hans-Peter Kiem, hicor, hutchinson institute for cancer outcomes research, immunotherapy, Martin Cheever, merkel cell carcinoma, palliative care, Paul Nghiem, Public Health Sciences, sickle cell disease, Stephen M Schwartz, Transplant and Immunotherapy
(RSS feeds are best viewed in browsers other than Chrome)
Immune booster may awaken body's defenses against skin cancer
Persistent HIV infection works a lot like cancer, study shows
Squelching ovarian cancer: the not-so-silent killer
Magazine Archive
Back issues of Hutch Magazine
Financial Reporting
Fiscal highlights & Annual Reports
Science Spotlight
Monthly review of Center-authored papers
Get updates via email.